Is Wegovy Daily or Weekly? How the Dosing Schedule Works

So is semaglutide daily or weekly when it comes to the injection?

The injection is weekly. Each Wegovy pen delivers one dose, and that dose covers the full seven days. The medicine's long half-life is the reason this works: semaglutide stays active in the body for roughly a week, so daily injections would simply lead to accumulation rather than better results. The once-weekly rhythm was built into the medicine's design from the start, not chosen for convenience after the fact.

You pick a day (Monday, Friday, whatever fits) and keep it consistent. If you need to shift your injection day by a day or two, the patient information leaflet in your pen box explains exactly how to do it without losing cover. Worth a one-minute read before you try.

Injection sites rotate between the abdomen, thigh and upper arm. There is no requirement to inject at the same time of day, which gives you real flexibility around work or travel. The weekly cadence is one of the features patients in clinical trials cited as making long-term use realistic. The STEP 1 trial, published in the New England Journal of Medicine, ran the injection schedule over 68 weeks and reported an average body-weight reduction of around 15% at the 2.4 mg maintenance dose.

Is there a daily Wegovy option, and how does it differ?

Yes, though it is a separate medicine, not a different form of the same pen. In June 2026, the MHRA approved daily oral semaglutide under the Wegovy brand name, making it the first oral GLP-1 medicine licensed in the UK for weight management. The tablet schedule runs once daily, first thing in the morning on an empty stomach with a small amount of plain water. You wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines.

The active ingredient is the same (semaglutide) but the formulation includes an absorption enhancer that allows it to pass through the gut wall. Because absorption is more variable with a tablet than an injection, the dose ladder is different: 1.5 mg, then 4 mg, then 9 mg, reaching a 25 mg maintenance dose. Trial data (OASIS 4, 64 weeks) showed an average weight loss of around 13.6% regardless of adherence, and roughly 17% among participants who stayed fully adherent throughout. No refrigeration is needed, which some people find easier for travel.

So the short answer is: injection Wegovy is weekly; tablet Wegovy is daily. They share a name and an active ingredient, but they are prescribed as distinct treatments and the right one depends on your clinical picture. Explore the Wegovy overview if you want to compare both formats in more detail.

How does the weekly injection titration schedule work?

You do not start at the full maintenance dose. The injection pathway begins at 0.25 mg weekly, a dose whose job is to let your body adjust rather than to drive significant weight loss from week one. After roughly four weeks, a prescriber typically moves you to 0.5 mg, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, the standard maintenance dose. The MHRA has also approved a 7.2 mg dose, initially delivered as three 2.4 mg pens per week and more recently available as a dedicated single-dose pen approved in April 2026.

Each step is a clinical decision. If side effects are difficult at a given dose, a prescriber may hold you there longer before moving up rather than pushing through on a fixed calendar. The semaglutide weekly injection guide covers what to expect at each stage. For a broader look at how GLP-1 medicines work as a class, the GLP-1 receptor agonist explainer adds useful context.

The NHS patient page for semaglutide also sets out the full schedule and what to do if a dose is missed, the leaflet inside your pen box should be your first reference for anything titration-related, and your prescriber the second.

Does the weekly or daily format affect eligibility?

The injection and the tablet carry slightly different eligibility criteria under their UK licences. Both require a BMI of 30 or above for standard eligibility; the injection also covers a BMI of 27 to 29.9 where at least one weight-related condition is present. The tablet carries the same 27–29.9 with a co-morbidity provision. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

Neither is available on the NHS through a standard GP route at present, the tablet launched as a private-prescription-only medicine, and the injection's NHS access remains limited to specialist services or specific NHS cohorts. If you are exploring the private route, a look at what Wegovy treatment costs privately gives you a realistic picture of what to budget. Treatment options across both formats are on the weight-loss treatments page, and if you want to understand the broader landscape before deciding, our weight management overview is a good starting point.

Whichever format interests you, suitability is assessed individually. Speak to our prescribers through a free consultation and a real clinician, not a form-processing system, will review your answers the same day.